Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Haleon Plc (HLN)
Haleon Plc (HLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,723,236
  • Shares Outstanding, K 4,617,287
  • Annual Sales, $ 10,858 M
  • Annual Income, $ 1,060 M
  • 60-Month Beta N/A
  • Price/Sales 2.83
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade HLN with:

Options Overview Details

View History
  • Implied Volatility 25.81% ( +25.81%)
  • Historical Volatility 25.21%
  • IV Percentile 15%
  • IV Rank 32.58%
  • IV High 63.72% on 09/08/22
  • IV Low 7.49% on 11/07/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 53
  • Volume Avg (30-Day) 136
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 5,687
  • Open Int (30-Day) 5,832

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.49 +9.75%
on 03/02/23
8.40 -2.08%
on 03/23/23
+0.30 (+3.79%)
since 02/27/23
3-Month
7.49 +9.75%
on 03/02/23
8.40 -2.08%
on 03/23/23
+0.27 (+3.40%)
since 12/27/22

Most Recent Stories

More News
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023

GSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive sales, making up for the lower sales of established drugs due to generic erosion.

GSK : 35.04 (+1.92%)
ANIK : 28.18 (+0.57%)
SNDX : 21.94 (+1.72%)
HLN : 8.22 (+0.61%)
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up

GSK's (GSK) revenues benefit from the strong growth in sales across all segments. The company raises the full-year sales guidance for all its segment

GSK : 35.04 (+1.92%)
JNJ : 153.30 (+0.43%)
PFE : 40.22 (-0.42%)
HLN : 8.22 (+0.61%)
Haleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK

Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice...

HLN : 8.22 (+0.61%)
Should Investors Bite Into Dan Loeb’s Latest Target?

Activist investor Dan Loeb has taken a nearly $1 stake in Colgate-Palmolive. He wants the company to unload its pet food business. 

CL : 74.15 (+0.99%)
HLN : 8.22 (+0.61%)
GSK : 35.04 (+1.92%)
PFE : 40.22 (-0.42%)
JNJ : 153.30 (+0.43%)
PG : 145.95 (-0.52%)
Haleon and Microsoft use AI to enhance health product accessibility for people who are blind or partially sighted

- On World Sight Day, Haleon and Microsoft are launching a joint effort to make health products more accessible for people who are blind or have low vision,...

HLN : 8.22 (+0.61%)
GSK's Key Drugs to Drive Sales in a Sluggish Second Half

GSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up for the lower sales of established drugs due to generic erosion.

GSK : 35.04 (+1.92%)
PFE : 40.22 (-0.42%)
VIR : 23.01 (+2.31%)
HLN : 8.22 (+0.61%)
Haleon plc Announces Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK

Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice...

HLN : 8.22 (+0.61%)
Nicorette is Motivating Smokers to Take Healthier Breaks with a Customized Music Listening Experience, SmokeLess Break Beats

/PRNewswire/ -- Today, Nicorette unveils SmokeLess Break Beats – a first-of-its kind, customized music listening experience that uses the science of music...

HLN : 8.22 (+0.61%)

Business Summary

Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and...

See More

Key Turning Points

3rd Resistance Point 8.36
2nd Resistance Point 8.30
1st Resistance Point 8.26
Last Price 8.22
1st Support Level 8.16
2nd Support Level 8.10
3rd Support Level 8.06

See More

52-Week High 8.50
Last Price 8.22
Fibonacci 61.8% 7.39
Fibonacci 50% 7.05
Fibonacci 38.2% 6.70
52-Week Low 5.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar